170 related articles for article (PubMed ID: 37815175)
1. No increased risk of intussusception after pentavalent rotavirus vaccination in China: a retrospective birth cohort using electronic health records of Ningbo city.
Liu Z; Li N; Liu G; Xu L; Dong Y; Meng R; Yang Y; Zhan S
Emerg Microbes Infect; 2023 Dec; 12(2):2270062. PubMed ID: 37815175
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Intussusception Following Pentavalent Rotavirus Vaccine (RotaTeq) Administration in 5 African Countries.
Tate JE; Mwenda JM; Keita AM; Tapsoba TW; Ngendahayo E; Kouamé BD; Samateh AL; Aliabadi N; Sissoko S; Traore Y; Bayisenga J; Sounkere-Soro M; Jagne S; Burke RM; Onwuchekwa U; Ouattara M; Bikoroti JB; N'Zue K; Leshem E; Coulibaly O; Ouedraogo I; Uwimana J; Sow S; Parashar UD;
Clin Infect Dis; 2024 Jan; 78(1):210-216. PubMed ID: 37596934
[TBL] [Abstract][Full Text] [Related]
3. Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq(®), in Kenya, including among HIV-infected and HIV-exposed infants.
Laserson KF; Nyakundi D; Feikin DR; Nyambane G; Cook E; Oyieko J; Ojwando J; Rivers SB; Ciarlet M; Neuzil KM; Breiman RF
Vaccine; 2012 Apr; 30 Suppl 1():A61-70. PubMed ID: 22520138
[TBL] [Abstract][Full Text] [Related]
4. Intussusception after Rotavirus Vaccine Introduction in India.
Reddy SN; Nair NP; Tate JE; Thiyagarajan V; Giri S; Praharaj I; Mohan VR; Babji S; Gupte MD; Arora R; Bidari S; Senthamizh S; Mekala S; Goru KB; Reddy B; Pamu P; Gorthi RP; Badur M; Mohan V; Sathpathy S; Mohanty H; Dash M; Mohakud NK; Ray RK; Mohanty P; Gathwala G; Chawla S; Gupta M; Gupta R; Goyal S; Sharma P; Mathew MA; Jacob TJK; Sundaram B; Purushothaman GKC; Dorairaj P; Jagannatham M; Murugiah K; Boopathy H; Maniam R; Gurusamy R; Kumaravel S; Shenoy A; Jain H; Goswami JK; Wakhlu A; Gupta V; Vinayagamurthy G; Parashar UD; Kang G
N Engl J Med; 2020 Nov; 383(20):1932-1940. PubMed ID: 33176083
[TBL] [Abstract][Full Text] [Related]
5. Relationship between Pentavalent Rotavirus Vaccine and Intussusception: A Retrospective Study at a Single Center in Korea.
Kim KY; Kim DS
Yonsei Med J; 2017 May; 58(3):631-636. PubMed ID: 28332371
[TBL] [Abstract][Full Text] [Related]
6. Analysis of hospitalizations due to intussusception in Sicily in the pre-rotavirus vaccination era (2003-2012).
Costantino C; Restivo V; Cuccia M; Furnari R; Amodio E; Vitale F
Ital J Pediatr; 2015 Aug; 41():52. PubMed ID: 26232152
[TBL] [Abstract][Full Text] [Related]
7. Intussusception risk after RotaTeq vaccination: evaluation from worldwide spontaneous reporting data using a self-controlled case series approach.
Escolano S; Hill C; Tubert-Bitter P
Vaccine; 2015 Feb; 33(8):1017-20. PubMed ID: 25596460
[TBL] [Abstract][Full Text] [Related]
8. Review of Over 15 Years Postmarketing Safety Surveillance Spontaneous Data for the Human Rotavirus Vaccine (Rotarix) on Intussusception.
Singh T; Delannois F; Haguinet F; Molo LY
Drug Saf; 2022 Feb; 45(2):155-168. PubMed ID: 35015268
[TBL] [Abstract][Full Text] [Related]
9. Intussusception following rotavirus vaccination: an updated review of the available evidence.
Rha B; Tate JE; Weintraub E; Haber P; Yen C; Patel M; Cortese MM; DeStefano F; Parashar UD
Expert Rev Vaccines; 2014 Nov; 13(11):1339-48. PubMed ID: 25066368
[TBL] [Abstract][Full Text] [Related]
10. Value of post-licensure data on benefits and risks of vaccination to inform vaccine policy: The example of rotavirus vaccines.
Parashar UD; Cortese MM; Payne DC; Lopman B; Yen C; Tate JE
Vaccine; 2015 Nov; 33 Suppl 4():D55-9. PubMed ID: 26122581
[TBL] [Abstract][Full Text] [Related]
11. Risk of intussusception after monovalent rotavirus vaccination.
Weintraub ES; Baggs J; Duffy J; Vellozzi C; Belongia EA; Irving S; Klein NP; Glanz JM; Jacobsen SJ; Naleway A; Jackson LA; DeStefano F
N Engl J Med; 2014 Feb; 370(6):513-9. PubMed ID: 24422678
[TBL] [Abstract][Full Text] [Related]
12. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia.
Buttery JP; Danchin MH; Lee KJ; Carlin JB; McIntyre PB; Elliott EJ; Booy R; Bines JE;
Vaccine; 2011 Apr; 29(16):3061-6. PubMed ID: 21316503
[TBL] [Abstract][Full Text] [Related]
13. Intussusception and Kawasaki disease after rotavirus vaccination in Taiwanese infants.
Huang WT; Juan YC; Liu CH; Yang YY; Chan KA
Vaccine; 2020 Sep; 38(40):6299-6303. PubMed ID: 32736940
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Intussusception After Oral Monovalent Rotavirus Vaccination in South Africa.
Groome MJ; Tate JE; Arnold M; Chitnis M; Cox S; de Vos C; Kirsten M; le Grange SM; Loveland J; Machaea S; Maharaj A; Andrews N; Madhi SA; Parashar UD
Clin Infect Dis; 2020 Apr; 70(8):1606-1612. PubMed ID: 31125061
[TBL] [Abstract][Full Text] [Related]
15. Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules.
Clark A; Tate J; Parashar U; Jit M; Hasso-Agopsowicz M; Henschke N; Lopman B; Van Zandvoort K; Pecenka C; Fine P; Sanderson C
Lancet Glob Health; 2019 Nov; 7(11):e1541-e1552. PubMed ID: 31607466
[TBL] [Abstract][Full Text] [Related]
16. Pentavalent rotavirus vaccine (RotaTeq): a review of its use in the prevention of rotavirus gastroenteritis in Europe.
Plosker GL
Drugs; 2010 Jun; 70(9):1165-88. PubMed ID: 20518582
[TBL] [Abstract][Full Text] [Related]
17. Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007.
Haber P; Patel M; Izurieta HS; Baggs J; Gargiullo P; Weintraub E; Cortese M; Braun MM; Belongia EA; Miller E; Ball R; Iskander J; Parashar UD
Pediatrics; 2008 Jun; 121(6):1206-12. PubMed ID: 18519491
[TBL] [Abstract][Full Text] [Related]
18. Risk of intussusception after monovalent rotavirus vaccine (Rotavac) in Indian infants: A self-controlled case series analysis.
INCLEN Intussusception Surveillance Network Study Group
Vaccine; 2021 Jan; 39(1):78-84. PubMed ID: 32972735
[TBL] [Abstract][Full Text] [Related]
19. Postmarketing surveillance of intussusception following mass introduction of the attenuated human rotavirus vaccine in Mexico.
Velázquez FR; Colindres RE; Grajales C; Hernández MT; Mercadillo MG; Torres FJ; Cervantes-Apolinar M; DeAntonio-Suarez R; Ortega-Barria E; Blum M; Breuer T; Verstraeten T
Pediatr Infect Dis J; 2012 Jul; 31(7):736-44. PubMed ID: 22695189
[TBL] [Abstract][Full Text] [Related]
20. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants.
Shui IM; Baggs J; Patel M; Parashar UD; Rett M; Belongia EA; Hambidge SJ; Glanz JM; Klein NP; Weintraub E
JAMA; 2012 Feb; 307(6):598-604. PubMed ID: 22318281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
